Alterity Therapeutics Directors’ Holdings Change
Company Announcements

Alterity Therapeutics Directors’ Holdings Change

Alterity Therapeutics (ATHE) has released an update.

Alterity Therapeutics Limited has reported a change in the interest of directors Mr. Brian Meltzer and Mr. Peter Marks as per the ASX listing rules. The change, dated 31st August 2024, involves the expiry of unlisted options without exercise or conversion. No new securities were acquired, but both directors saw a decrease in the number of options held.

For further insights into ATHE stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyAlterity Therapeutics announces presentation on bioMUSE study
TheFlyAlterity Therapeutics announces new publication on ATH434
TheFlyAlterity Therapeutics reports cash balance of A$9.28M as of September 30
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App